Central European Journal of Immunology (Aug 2021)
Severe hypereosinophilic syndrome successfully treated with a monoclonal antibody against interleukin 5 receptor α – benralizumab
Abstract
No abstracts available.Keywords
Central European Journal of Immunology (Aug 2021)